EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Antibody responses to respiratory syncytial virus: a population-based cross-sectional serological study in Southern China, 2021

Qianli Wang, Nuolan Liu, Yan Wang, Tracy J Ruckwardt, Meng Xu, Jianan Wu, Juanjuan Zhang, Xiaofeng Tong, Jiaxin Zhou, Jiqun Lin, Yuxia Liang, Juan Yang und 3 weitere

Clinical Microbiology and Infection · 2024-09 · 30 (9) · 1183-1189

DOI: 10.1016/j.cmi.2024.06.005 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Clinical Microbiology and Infection, 2024-09. Verfasst von Qianli Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China; Shanghai Institute of Infe…. Hauptthemen laut MEDLINE: Antibodies, Viral, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, Immunoglobulin G. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, Gates Ventures, GlaxoSmithKline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: With remarkable progress in the field of respiratory syncytial virus (RSV) prophylaxis, it is critical to understand population immunity against RSV. We aim to describe the RSV pre-F IgG antibodies across all age groups in Southern China and to evaluate the risk factors associated with lower antibody levels. METHODS: We performed a community-based cross-sectional sero-epidemiological study in Anhua County, Hunan Province, Southern China, from July 15, 2021, to November 5, 2021. Serum samples were tested for IgG antibodies against the RSV prefusion F (pre-F) protein using an enzyme-linked immunosorbent assay. We estimated the geometric mean titres (GMTs) and seropositivity rates across all age groups. The generalized linear models were built to identify factors associated with antibody levels. RESULTS: A total of 890 participants aged 4 months to older than 89 years were enrolled. The lowest RSV pre-F IgG GMTs were observed in infants and toddlers aged 4 months to younger than 2 years (3.0; 95% CI, 2.6-3.5). With increasing age, the RSV pre-F IgG GMT increased to 4.3 (95% CI, 4.1-4.4) between the ages of 2 and younger than 5 years and then stabilized at high levels throughout life. All the children had serological evidence of RSV infection by the age of 5 years. Age was associated with RSV pre-F antibody levels in children, with an estimated 1.9-fold (95% CI, 0.8-3.6) increase in titre per year before 5 years of age, although it was not significantly associated with antibody levels in adults aged older than 60 years. DISCUSSION: Our findings could provide a comprehensive understanding of the gaps in RSV immunity at the population level and inform the prioritization of immunization platforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanImmunoglobulin GHumansChinaCross-Sectional StudiesInfantChild, PreschoolAdultMiddle AgedFemaleMaleChildYoung AdultAgedAdolescentSeroepidemiologic StudiesAged, 80 and overEnzyme-Linked Immunosorbent AssayAntibody FormationRisk Factors

Stichwörter der Autor:innen

Cross-sectional studyGeneral populationPre-F IgG antibodyRespiratory syncytial virusSerology

Substanzen

Antibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
  • School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Vaccine Research Centre, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Anhua County Centre for Disease Control and Prevention, Yiyang, China.
  • Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
  • School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China. Ele…

Förderung

  • Intramural NIH HHS
  • Gates Ventures
  • GlaxoSmithKline
  • Sanofi Pasteur
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Wang, Q., Liu, N., Wang, Y., Ruckwardt, T. J., Xu, M., Wu, J., Zhang, J., Tong, X., Zhou, J., Lin, J., Liang, Y., Yang, J., Yi, L., Chu, H. Y., & Yu, H. (2024). Antibody responses to respiratory syncytial virus: a population-based cross-sectional serological study in Southern China, 2021. Clinical Microbiology and Infection, 30(9), 1183-1189. https://doi.org/10.1016/j.cmi.2024.06.005

Vancouver

Wang Q, Liu N, Wang Y, Ruckwardt TJ, Xu M, Wu J, et al. Antibody responses to respiratory syncytial virus: a population-based cross-sectional serological study in Southern China, 2021. Clinical Microbiology and Infection. 2024;30(9):1183-1189. doi:10.1016/j.cmi.2024.06.005

BibTeX
@article{Wang2024,
  author = {Wang, Qianli and Liu, Nuolan and Wang, Yan and Ruckwardt, Tracy J and Xu, Meng and Wu, Jianan and Zhang, Juanjuan and Tong, Xiaofeng and Zhou, Jiaxin and Lin, Jiqun and Liang, Yuxia and Yang, Juan and Yi, Lan and Chu, Helen Y and Yu, Hongjie},
  title = {Antibody responses to respiratory syncytial virus: a population-based cross-sectional serological study in Southern China, 2021},
  journal = {Clinical Microbiology and Infection},
  year = {2024},
  volume = {30},
  number = {9},
  pages = {1183--1189},
  doi = {10.1016/j.cmi.2024.06.005}
}
Kostenlos starten →